Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Schultz, R; Mattila, J; Gappa, M; Verronen, P
   Development of progressive pulmonary interstitial and intra-alveolar cholesterol granulomas (PICG) associated with therapy-resistant chronic systemicjuvenile arthritis (CJA)
   PEDIATRIC PULMONOLOGY
   
   R. Schultz et al., "Development of progressive pulmonary interstitial and intra-alveolar cholesterol granulomas (PICG) associated with therapy-resistant chronic systemicjuvenile arthritis (CJA)", PEDIAT PULM, 32(5), 2001, pp. 397-402
2. Song, YF; Yang, P
   Synthesis of novel potential antitumor agents: 2,6-dimethoxyhydroquinone-3-mercapto-acetyl peptide conjugates
   PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY
   
   Y.F. Song e P. Yang, "Synthesis of novel potential antitumor agents: 2,6-dimethoxyhydroquinone-3-mercapto-acetyl peptide conjugates", PREP BIOC B, 31(4), 2001, pp. 411-420
3. Pepper, C; Hooper, K; Thomas, A; Hoy, T; Bentley, P
   Bcl-2 antisense oligonucleotides enhance the cytotoxicity of Chlorambucil in B-cell chronic lymphocytic leukaemia cells
   LEUKEMIA & LYMPHOMA
   
   C. Pepper et al., "Bcl-2 antisense oligonucleotides enhance the cytotoxicity of Chlorambucil in B-cell chronic lymphocytic leukaemia cells", LEUK LYMPH, 42(3), 2001, pp. 491-498
4. Robak, T; Blonski, JZ; Kasznicki, M
   Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?
   LEUKEMIA & LYMPHOMA
   
   T. Robak et al., "Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?", LEUK LYMPH, 41(5-6), 2001, pp. 545-557
5. Wang, AYM; Li, PKT; Lai, FMM; Chow, KM; Szeto, CC; Leung, CB; Lui, SF
   Severe bone marrow failure associated with the use of alternating steroid with chlorambucil in lupus membranous nephropathy in Chinese
   LUPUS
   
   A.Y.M. Wang et al., "Severe bone marrow failure associated with the use of alternating steroid with chlorambucil in lupus membranous nephropathy in Chinese", LUPUS, 10(4), 2001, pp. 295-298
6. Morton, SJ; Powell, RJ
   Management of systemic lupus erythematosus (SLE)
   CLINICAL AND EXPERIMENTAL ALLERGY
   
   S.J. Morton e R.J. Powell, "Management of systemic lupus erythematosus (SLE)", CLIN EXP AL, 31(5), 2001, pp. 686-693
7. Ponticelli, C; Passerini, P
   Treatment of membranous nephropathy
   NEPHROLOGY DIALYSIS TRANSPLANTATION
   
   C. Ponticelli e P. Passerini, "Treatment of membranous nephropathy", NEPH DIAL T, 16, 2001, pp. 8-10
8. Latta, K; von Schnakenburg, C; Ehrich, JHH
   A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children
   PEDIATRIC NEPHROLOGY
   
   K. Latta et al., "A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children", PED NEPHROL, 16(3), 2001, pp. 271-282
9. Takeda, A; Takimoto, H; Mizusawa, Y; Simoda, M
   Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome
   PEDIATRIC NEPHROLOGY
   
   A. Takeda et al., "Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome", PED NEPHROL, 16(11), 2001, pp. 888-893
10. Tefferi, A; Li, CY; Reeder, CB; Geyer, SM; Allmer, C; Levitt, R; Michalak, JC; Addo, F; Krook, JE; Witzig, TE; Schaefer, PL; Mailliard, JA
    A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia
    LEUKEMIA
    
    A. Tefferi et al., "A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia", LEUKEMIA, 15(8), 2001, pp. 1171-1175
11. Robak, T; Blonski, JZ; Kasznicki, M; Gora-Tybor, J; Dwilewicz-Trojaczek, J; Boguradzki, P; Konopka, L; Ceglarek, B; Sulek, J; Kuliczkowski, K; Wolowiec, D; Stella-Holowiecka, B; Skotnicki, AB; Nowak, W; Moskwa-Sroka, B; Dmoszynska, A; Calbecka, M
    Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia
    LEUKEMIA
    
    T. Robak et al., "Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia", LEUKEMIA, 15(10), 2001, pp. 1510-1516
12. O'Brien, SM; Kantarjian, AM; Cortes, J; Beran, M; Koller, CA; Giles, FJ; Lerner, S; Keating, M
    Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia
    JOURNAL OF CLINICAL ONCOLOGY
    
    S.M. O'Brien et al., "Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia", J CL ONCOL, 19(5), 2001, pp. 1414-1420
13. Beyer, U; Rothen-Rutishauser, B; Unger, C; Wunderli-Allenspach, H; Kratz, F
    Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy
    PHARMACEUTICAL RESEARCH
    
    U. Beyer et al., "Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy", PHARM RES, 18(1), 2001, pp. 29-38
14. Byrd, JC; Shinn, C; Willis, CR; Flinn, IW; Lehman, T; Suasville, E; Lucas, D; Gerver, MR
    UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism
    EXPERIMENTAL HEMATOLOGY
    
    J.C. Byrd et al., "UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism", EXP HEMATOL, 29(6), 2001, pp. 703-708
15. Branten, AJW; Wetzels, JFM
    Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency
    CLINICAL NEPHROLOGY
    
    A.J.W. Branten e J.F.M. Wetzels, "Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency", CLIN NEPHR, 56(1), 2001, pp. 1-9
16. Kimby, E; Brandt, L; Nygren, P; Glimelius, B
    A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia
    ACTA ONCOLOGICA
    
    E. Kimby et al., "A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia", ACTA ONCOL, 40(2-3), 2001, pp. 224-230
17. Bazzi, C; Petrini, C; Rizza, V; Arrigo, G; Beltrame, A; Pisano, L; D'Amico, G
    Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    C. Bazzi et al., "Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy", AM J KIDNEY, 38(2), 2001, pp. 240-248
18. Jin, GZ; You, YJ; Kim, Y; Nam, NH; Ahn, BZ
    Esters of chlorambucil with 2-substituted 1,4-dihydroxy-9,10-anthraquinones as multifunctional anticancer agents
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    
    G.Z. Jin et al., "Esters of chlorambucil with 2-substituted 1,4-dihydroxy-9,10-anthraquinones as multifunctional anticancer agents", EUR J MED C, 36(4), 2001, pp. 361-366
19. Durkan, AM; Hodson, EM; Willis, NS; Craig, JC
    Immunosuppressive agents in childhood nephrotic syndrome: A meta-analysis of randomized controlled trials
    KIDNEY INTERNATIONAL
    
    A.M. Durkan et al., "Immunosuppressive agents in childhood nephrotic syndrome: A meta-analysis of randomized controlled trials", KIDNEY INT, 59(5), 2001, pp. 1919-1927
20. Cattran, DC; Appel, GB; Hebert, LA; Hunsicker, LG; Pohl, MA; Hoy, WE; Maxwell, DR; Kunis, CL
    Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial
    KIDNEY INTERNATIONAL
    
    D.C. Cattran et al., "Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial", KIDNEY INT, 59(4), 2001, pp. 1484-1490
21. Rai, KR
    Fludarabine for chronic lymphocytic leukemia. Reply
    NEW ENGLAND JOURNAL OF MEDICINE
    
    K.R. Rai, "Fludarabine for chronic lymphocytic leukemia. Reply", N ENG J MED, 344(15), 2001, pp. 1167-1168
22. Batlle, M; Ribera, JM; Oriol, A; Rodriguez, L; Cirauqui, B; Xicoy, B; Grau, J; Feliu, J; Flores, A; Milla, F
    Pneumonias in patients with chronic lymphocytic leukemia. Study of 30 episodes
    MEDICINA CLINICA
    
    M. Batlle et al., "Pneumonias in patients with chronic lymphocytic leukemia. Study of 30 episodes", MED CLIN, 116(19), 2001, pp. 738-740
23. Watson, KJ; Anderson, DR; Nguyen, ST
    Toward polymeric anticancer drug cocktails from ring-opening metathesis polymerization
    MACROMOLECULES
    
    K.J. Watson et al., "Toward polymeric anticancer drug cocktails from ring-opening metathesis polymerization", MACROMOLEC, 34(11), 2001, pp. 3507-3509
24. Langer, M; Kratz, F; Rothen-Rutishauser, B; Wunderli-Allenspach, H; Beck-Sickinger, AG
    Novel peptide conjugates for tumor-specific chemotherapy
    JOURNAL OF MEDICINAL CHEMISTRY
    
    M. Langer et al., "Novel peptide conjugates for tumor-specific chemotherapy", J MED CHEM, 44(9), 2001, pp. 1341-1348
25. Waheed, NK; Miserocchi, E; Foster, CS
    Ocular concerns in juvenile rheumatoid arthritis
    INTERNATIONAL OPHTHALMOLOGY CLINICS
    
    N.K. Waheed et al., "Ocular concerns in juvenile rheumatoid arthritis", INT OPHTH C, 41(4), 2001, pp. 223-234
26. Robillard, MS; Jansen, BAJ; Lochner, M; Geneste, H; Brouwer, J; Hesse, M; Reedijk, J
    Mononuclear tetraamineplatinum(II) complexes: Synthesis, anticancer activity, DNA binding, and cellular uptake
    HELVETICA CHIMICA ACTA
    
    M.S. Robillard et al., "Mononuclear tetraamineplatinum(II) complexes: Synthesis, anticancer activity, DNA binding, and cellular uptake", HELV CHIM A, 84(10), 2001, pp. 3023-3030
27. Sallach, S; Schmidt, T; Pehl, C; Gallenberger, S; Keiditsch, E; Starostik, P; Ott, G; Schepp, W
    Primary low-grade B cell non-Hodgkin's lymphoma of MALT type simultaneously arising in the colon and in the lung - Report of a case
    DISEASES OF THE COLON & RECTUM
    
    S. Sallach et al., "Primary low-grade B cell non-Hodgkin's lymphoma of MALT type simultaneously arising in the colon and in the lung - Report of a case", DIS COL REC, 44(3), 2001, pp. 448-452
28. Kozin, SV; Shkarin, P; Gerweck, LE
    The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acid chemotherapeutics
    CANCER RESEARCH
    
    S.V. Kozin et al., "The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acid chemotherapeutics", CANCER RES, 61(12), 2001, pp. 4740-4743
29. Wickremasinghe, RG; Ganeshaguru, K; Jones, DT; Lindsay, C; Spanswick, VJ; Hartley, JA; Wadhwa, M; Thorpe, R; Hoffbrand, AV; Prentice, HG; Mehta, AB
    Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells
    BRITISH JOURNAL OF HAEMATOLOGY
    
    R.G. Wickremasinghe et al., "Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells", BR J HAEM, 114(3), 2001, pp. 608-615
30. Monks, NR; Blakey, DC; Curtin, NJ; East, SJ; Heuze, A; Newell, DR
    Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue
    BRITISH JOURNAL OF CANCER
    
    N.R. Monks et al., "Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue", BR J CANC, 85(5), 2001, pp. 764-771
31. Leporrier, M; Chevret, S; Cazin, B; Boudjerra, N; Feugier, P; Desablens, B; Rapp, MJ; Jaubert, J; Autrand, C; Divine, M; Dreyfus, B; Maloum, K; Travade, P; Dighiero, G; Binet, JL; Chastang, C
    Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients
    BLOOD
    
    M. Leporrier et al., "Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients", BLOOD, 98(8), 2001, pp. 2319-2325
32. Hallek, M; Schmitt, B; Emmerich, B; Stein, H
    Chronic lymphocytic leukemia - Part 2: Treatment
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    
    M. Hallek et al., "Chronic lymphocytic leukemia - Part 2: Treatment", DEUT MED WO, 126(23), 2001, pp. 690-695
33. Vega-Perez, JM; Candela, JI; Romero, I; Blanco, E; Iglesias-Guerra, F
    Potential anticancer drugs, 4 - Glycosyl glycerol derivatives as drug carrier system. Stereoselective synthesis of epoxyalkyl N-acyl-beta-D-glucopyranosides and their reactivity with nucleophiles
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    
    J.M. Vega-Perez et al., "Potential anticancer drugs, 4 - Glycosyl glycerol derivatives as drug carrier system. Stereoselective synthesis of epoxyalkyl N-acyl-beta-D-glucopyranosides and their reactivity with nucleophiles", EUR J ORG C, (23), 2000, pp. 3949-3956
34. Wu, XC; Marcinkowski, K; Turner, PM; Ferguson, LR
    Mutations induced by some DNA minor groove binding alkylators in AS52 Chinese hamster cells
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    
    X.C. Wu et al., "Mutations induced by some DNA minor groove binding alkylators in AS52 Chinese hamster cells", MUT RES-F M, 448(1), 2000, pp. 35-45
35. Salmelin, C; Hovinen, J; Vilpo, J
    Polymyxin permeabilization as a tool to investigate cytotoxicity of therapeutic aromatic alkylators in DNA repair-deficient Escherichia coli strains
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    
    C. Salmelin et al., "Polymyxin permeabilization as a tool to investigate cytotoxicity of therapeutic aromatic alkylators in DNA repair-deficient Escherichia coli strains", MUT RES-GTE, 467(2), 2000, pp. 129-138
36. Cattran, D
    Management of membranous nephropathy
    NEPHROLOGY
    
    D. Cattran, "Management of membranous nephropathy", NEPHROLOGY, 5(4), 2000, pp. 209-213
37. Kalil, N; Cheson, BD
    Management of chronic lymphocytic leukaemia
    DRUGS & AGING
    
    N. Kalil e B.D. Cheson, "Management of chronic lymphocytic leukaemia", DRUG AGING, 16(1), 2000, pp. 9-27
38. Piccoli, A
    Elementary clinical decision analysis in evidence-based nephrology
    JOURNAL OF NEPHROLOGY
    
    A. Piccoli, "Elementary clinical decision analysis in evidence-based nephrology", J NEPHROL, 13(6), 2000, pp. 419-432
39. Prescott, DM; Charles, HC; Poulson, JM; Page, RL; Thrall, DE; Vujaskovic, Z; Dewhirst, MW
    The relationship between intracellular and extracellular pH in spontaneouscanine tumors
    CLINICAL CANCER RESEARCH
    
    D.M. Prescott et al., "The relationship between intracellular and extracellular pH in spontaneouscanine tumors", CLIN CANC R, 6(6), 2000, pp. 2501-2505
40. Kratz, F; Roth, T; Fichiner, I; Schumacher, P; Fiebig, HH; Unger, C
    In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mammacarcinoma model
    JOURNAL OF DRUG TARGETING
    
    F. Kratz et al., "In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mammacarcinoma model", J DRUG TAR, 8(5), 2000, pp. 305-318
41. Zotos, A; Marinos, E; Sekeri-Pataryas, KE; Sourlingasb, TG
    A morphological study of the effect of chlorambucil during the S and G2 phases of the cell cycle of synchronized HEp-2 cancer cell populations using computerized morphometry
    MICRON
    
    A. Zotos et al., "A morphological study of the effect of chlorambucil during the S and G2 phases of the cell cycle of synchronized HEp-2 cancer cell populations using computerized morphometry", MICRON, 31(6), 2000, pp. 623-629
42. Weiss, MA; Glenn, M; Maslak, P; Rahman, Z; Noy, A; Zelenetz, A; Scheinberg, DA; Golde, DW
    Consolidation therapy with high-dose cyclophosphamide improves the qualityof response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy
    LEUKEMIA
    
    M.A. Weiss et al., "Consolidation therapy with high-dose cyclophosphamide improves the qualityof response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy", LEUKEMIA, 14(9), 2000, pp. 1577-1582
43. Van den Neste, E; Louviaux, I; Michaux, JL; Delannoy, A; Michaux, L; Sonet, A; Bosly, A; Doyen, C; Mineur, P; Andre, M; Straetmans, N; Coche, E; Venet, C; Duprez, T; Ferrant, A
    Phase I/II study of 2-chloro-2 '-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent. non-Hodgkin's lymphoma
    LEUKEMIA
    
    E. Van den Neste et al., "Phase I/II study of 2-chloro-2 '-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent. non-Hodgkin's lymphoma", LEUKEMIA, 14(6), 2000, pp. 1136-1142
44. Alexopoulos, E; Papagianni, A
    Treatment of idiopathic membranous nephropathy (IMN)
    RENAL FAILURE
    
    E. Alexopoulos e A. Papagianni, "Treatment of idiopathic membranous nephropathy (IMN)", RENAL FAIL, 22(6), 2000, pp. 697-709
45. Juillard, L; Fouque, D
    Treatment of idiopathic membranous glomerulonephritis
    PRESSE MEDICALE
    
    L. Juillard e D. Fouque, "Treatment of idiopathic membranous glomerulonephritis", PRESSE MED, 29(16), 2000, pp. 923-929
46. Zinzani, PL; Bendandi, M; Magagnoli, M; Albertini, P; Rondelli, D; Stefoni, V; Tani, M; Tura, S
    Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemia
    HAEMATOLOGICA
    
    P.L. Zinzani et al., "Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemia", HAEMATOLOG, 85(11), 2000, pp. 1135-1139
47. Lockett, T; Reilly, W; Manthey, M; Wells, X; Cameron, F; Moghaddam, M; Johnston, J; Smith, K; Francis, C; Yang, Q; Whittaker, R
    Tris lipidation: A chemically flexible technology for modifying the delivery of drugs and genes
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    
    T. Lockett et al., "Tris lipidation: A chemically flexible technology for modifying the delivery of drugs and genes", CLIN EXP PH, 27(7), 2000, pp. 563-567
48. Zhang, K; Yang, EB; Zhao, YN; Wong, KP; Mack, P
    Glutathione-related factors are not correlated with sensitivity of human tumour cells to actinomycin D
    CANCER LETTERS
    
    K. Zhang et al., "Glutathione-related factors are not correlated with sensitivity of human tumour cells to actinomycin D", CANCER LETT, 149(1-2), 2000, pp. 213-220
49. Kingreen, H; Straube, R
    AT(1)-receptor blocker in idopathic chronic membranous glomerulonephritis
    NIEREN-UND HOCHDRUCKKRANKHEITEN
    
    H. Kingreen e R. Straube, "AT(1)-receptor blocker in idopathic chronic membranous glomerulonephritis", NIEREN HOCH, 29(1), 2000, pp. 34-40
50. Miller, G; Zimmerman, R; Radhakrishnan, J; Appel, G
    Use of mycophenolate mofetil in resistant membranous nephropathy
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    G. Miller et al., "Use of mycophenolate mofetil in resistant membranous nephropathy", AM J KIDNEY, 36(2), 2000, pp. 250-256
51. Patel, SP; Nast, CC; Adler, SG
    Chlorambucil-induced acute hepatic failure in a patient with membranous nephropathy
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    S.P. Patel et al., "Chlorambucil-induced acute hepatic failure in a patient with membranous nephropathy", AM J KIDNEY, 36(2), 2000, pp. 401-404
52. Geddes, CC; Cattran, DC
    The treatment of idiopathic membranous nephropathy
    SEMINARS IN NEPHROLOGY
    
    C.C. Geddes e D.C. Cattran, "The treatment of idiopathic membranous nephropathy", SEM NEPHROL, 20(3), 2000, pp. 299-308
53. Vigil, A; Oliet, A; Gallar, P; Ortega, O; Villarreal, IR
    Steroid and immunosuppressive treatment in idiopathic membranous glomerulonephritis
    NEFROLOGIA
    
    A. Vigil et al., "Steroid and immunosuppressive treatment in idiopathic membranous glomerulonephritis", NEFROLOGIA, 20(3), 2000, pp. 291-294
54. He, T; Wei, D; Fabris, D; Fenselau, C
    Intracellular sequestration of anti-tumor drugs by metallothionein
    CELLULAR AND MOLECULAR BIOLOGY
    
    T. He et al., "Intracellular sequestration of anti-tumor drugs by metallothionein", CELL MOL B, 46(2), 2000, pp. 383-392
55. Thomas, A; Pepper, C; Hoy, T; Bentley, P
    Bcl-2 and Bax expression and chlorambucil-induced apoptosis in the T-cellsand leukaemic B-cells of untreated B-cell chronic lymphocytic leukaemia patients
    LEUKEMIA RESEARCH
    
    A. Thomas et al., "Bcl-2 and Bax expression and chlorambucil-induced apoptosis in the T-cellsand leukaemic B-cells of untreated B-cell chronic lymphocytic leukaemia patients", LEUK RES, 24(10), 2000, pp. 813-821
56. Weiss, MA
    A phase I and II study of pentostatin (Nipent) with cyclophosphamide for previously treated patients with chronic lymphocytic leukemia
    SEMINARS IN ONCOLOGY
    
    M.A. Weiss, "A phase I and II study of pentostatin (Nipent) with cyclophosphamide for previously treated patients with chronic lymphocytic leukemia", SEMIN ONCOL, 27(2), 2000, pp. 41-43
57. Szilagyi, Z; Fenselau, C
    Molecular dynamics simulation of metallothionein-drug complexes
    DRUG METABOLISM AND DISPOSITION
    
    Z. Szilagyi e C. Fenselau, "Molecular dynamics simulation of metallothionein-drug complexes", DRUG META D, 28(2), 2000, pp. 174-179
58. McCully, KS; Narayansingh, GV; Cumming, GP; Sarkar, TK; Parkin, DE
    A reappraisal of the role of chlorambucil in patients with end stage ovarian cancer who have previously been treated with platinum regimens
    SCOTTISH MEDICAL JOURNAL
    
    K.S. McCully et al., "A reappraisal of the role of chlorambucil in patients with end stage ovarian cancer who have previously been treated with platinum regimens", SCOT MED J, 45(2), 2000, pp. 51-53
59. Robak, T; Szmigielska, A
    Dexamethasone does not enhance antileukemic activity of cladribine in micewith leukemias L1210 and P388
    NEOPLASMA
    
    T. Robak e A. Szmigielska, "Dexamethasone does not enhance antileukemic activity of cladribine in micewith leukemias L1210 and P388", NEOPLASMA, 47(3), 2000, pp. 168-171
60. Rosario, LA; O'Brien, ML; Henderson, CJ; Wolf, CR; Tew, KD
    Cellular response to a glutathione S-transferase P1-1 activated prodrug
    MOLECULAR PHARMACOLOGY
    
    L.A. Rosario et al., "Cellular response to a glutathione S-transferase P1-1 activated prodrug", MOLEC PHARM, 58(1), 2000, pp. 167-174
61. Bennett, ML; Jackson, JM; Jorizzo, JL; Fleischer, AB; White, WL; Callen, JP
    A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions
    MEDICINE
    
    M.L. Bennett et al., "A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions", MEDICINE, 79(1), 2000, pp. 37-46
62. O'Brien, M; Kruh, GD; Tew, KD
    The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M. O'Brien et al., "The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance", J PHARM EXP, 294(2), 2000, pp. 480-487
63. Phanstiel, O; Price, HL; Wang, L; Juusola, J; Kline, M; Shah, SM
    The effect of polyamine homologation on the transport and cytotoxicity properties of polyamine-(DNA-intercalator) conjugates
    JOURNAL OF ORGANIC CHEMISTRY
    
    O. Phanstiel et al., "The effect of polyamine homologation on the transport and cytotoxicity properties of polyamine-(DNA-intercalator) conjugates", J ORG CHEM, 65(18), 2000, pp. 5590-5599
64. Kratz, F; Muller-Driver, R; Hofmann, I; Drevs, J; Unger, C
    A novel macromolecular prodrug concept exploiting endogenous serum albuminas a drug carrier for cancer chemotherapy
    JOURNAL OF MEDICINAL CHEMISTRY
    
    F. Kratz et al., "A novel macromolecular prodrug concept exploiting endogenous serum albuminas a drug carrier for cancer chemotherapy", J MED CHEM, 43(7), 2000, pp. 1253-1256
65. Bielawska, A; Bielawski, K; Chrzanowski, K; Wolczynski, S
    Prolidase-activated prodrug for cancer chemotherapy - Cytotoxic activity of proline analogue of chlorambucil in breast cancer MCF-7 cells
    FARMACO
    
    A. Bielawska et al., "Prolidase-activated prodrug for cancer chemotherapy - Cytotoxic activity of proline analogue of chlorambucil in breast cancer MCF-7 cells", FARMACO, 55(11-12), 2000, pp. 736-741
66. Ferguson, LR; Liu, AP; Denny, WA; Cullinane, C; Talarico, T; Phillips, DR
    Transcriptional blockages in a cell-free system by sequence-selective DNA alkylating agents
    CHEMICO-BIOLOGICAL INTERACTIONS
    
    L.R. Ferguson et al., "Transcriptional blockages in a cell-free system by sequence-selective DNA alkylating agents", CHEM-BIO IN, 126(1), 2000, pp. 15-31
67. Kyle, RA; Greipp, PR; Gertz, MA; Witzig, TE; Lust, JA; Lacy, MQ; Therneau, TM
    Waldenstrom's macroglobulinaemia: a prospective study comparing daily withintermittent oral chlorambucil
    BRITISH JOURNAL OF HAEMATOLOGY
    
    R.A. Kyle et al., "Waldenstrom's macroglobulinaemia: a prospective study comparing daily withintermittent oral chlorambucil", BR J HAEM, 108(4), 2000, pp. 737-742
68. Robak, T; Blonski, JZ; Kasznicki, M; Konopka, L; Ceglarek, B; Dmoszynska, A; Soroka-Wojtaszko, M; Skotnicki, AB; Nowak, W; Dwilewicz-Trojaczek, J; Tomaszewska, A; Hellmann, A; Lewandowski, K; Kuliczkowski, K; Potoczek, S; Zdziarska, B; Hansz, J; Kroll, R; Komarnicki, M; Holowiecki, J; Grieb, P
    Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients
    BRITISH JOURNAL OF HAEMATOLOGY
    
    T. Robak et al., "Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients", BR J HAEM, 108(2), 2000, pp. 357-368
69. Flinn, IW; Byrd, JC; Morrison, C; Jamison, J; Diehl, LF; Murphy, T; Piantadosi, S; Seifter, E; Ambinder, RF; Vogelsang, G; Grever, MR
    Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies
    BLOOD
    
    I.W. Flinn et al., "Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies", BLOOD, 96(1), 2000, pp. 71-75
70. Pandya, U; Srivastava, SK; Singhal, SS; Pal, A; Awasthi, S; Zimniak, P; Awasthi, YC; Singh, SV
    Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    U. Pandya et al., "Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil", BIOC BIOP R, 278(1), 2000, pp. 258-262
71. Pallone, TL; Papadimitriou, JC
    A 65-year-old man with chronic back pain and shortness of breath - Renal amyloidosis.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    
    T.L. Pallone e J.C. Papadimitriou, "A 65-year-old man with chronic back pain and shortness of breath - Renal amyloidosis.", AM J MED SC, 320(3), 2000, pp. 195-201
72. Laxer, RM
    Long-term toxicity of immune suppression in juvenile rheumatic diseases
    RHEUMATOLOGY
    
    R.M. Laxer, "Long-term toxicity of immune suppression in juvenile rheumatic diseases", RHEUMATOLOG, 38(8), 1999, pp. 743-746
73. Davies, ID; Allanson, JP; Causon, RC
    Rapid determination of the anti-cancer drug chlorambucil (Leukeran (TM)) and its phenyl acetic acid mustard metabolite in human serum and plasma by automated solid-phase extraction and liquid chromatography-tandem mass spectrometry
    JOURNAL OF CHROMATOGRAPHY B
    
    I.D. Davies et al., "Rapid determination of the anti-cancer drug chlorambucil (Leukeran (TM)) and its phenyl acetic acid mustard metabolite in human serum and plasma by automated solid-phase extraction and liquid chromatography-tandem mass spectrometry", J CHROMAT B, 732(1), 1999, pp. 173-184
74. Ponticelli, C; Passerini, P
    The place of cyclosporin in the management of primary nephrotic syndrome
    BIODRUGS
    
    C. Ponticelli e P. Passerini, "The place of cyclosporin in the management of primary nephrotic syndrome", BIODRUGS, 12(5), 1999, pp. 327-341
75. Schena, FP
    Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients
    JOURNAL OF NEPHROLOGY
    
    F.P. Schena, "Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients", J NEPHROL, 12, 1999, pp. S125-S130
76. Cullis, PM; Green, RE; Merson-Davies, L; Travis, N
    Probing the mechanism of transport and compartmentalisation of polyamines in mammalian cells
    CHEMISTRY & BIOLOGY
    
    P.M. Cullis et al., "Probing the mechanism of transport and compartmentalisation of polyamines in mammalian cells", CHEM BIOL, 6(10), 1999, pp. 717-729
77. Ponticelli, C; Cresseri, D
    Immunosuppressive therapy in primary glomerulonephritis
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    
    C. Ponticelli e D. Cresseri, "Immunosuppressive therapy in primary glomerulonephritis", CURR OP NEP, 8(2), 1999, pp. 187-192
78. Zhang, K; Yang, EB; Wong, KP; Mack, P
    GSH, GSH-related enzymes and GS-X pump in relation to sensitivity of humantumor cell lines to chlorambucil and adriamycin
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    K. Zhang et al., "GSH, GSH-related enzymes and GS-X pump in relation to sensitivity of humantumor cell lines to chlorambucil and adriamycin", INT J ONCOL, 14(5), 1999, pp. 861-867
79. Rodrigues, PCA; Beyer, U; Schumacher, P; Roth, T; Fiebig, HH; Unger, C; Messori, L; Orioli, P; Paper, DH; Mulhaupt, R; Kratz, F
    Acid-sensitive polyethylene glycol conjugates of doxorubicin: Preparation,in vitro efficacy and intracellular distribution
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    P.C.A. Rodrigues et al., "Acid-sensitive polyethylene glycol conjugates of doxorubicin: Preparation,in vitro efficacy and intracellular distribution", BIO MED CH, 7(11), 1999, pp. 2517-2524
80. Wagner, AM; Brunet, S; Puig, J; Ortega, E; Subira, M; Puig, M
    Chlorambucil-induced inappropriate antidiuresis in a man with chronic lymphocytic leukemia
    ANNALS OF HEMATOLOGY
    
    A.M. Wagner et al., "Chlorambucil-induced inappropriate antidiuresis in a man with chronic lymphocytic leukemia", ANN HEMATOL, 78(1), 1999, pp. 37-38
81. Suwalsky, M; Hernandez, P; Villena, F; Sotomayor, CP
    The anticancer drug chlorambucil interacts with the human erythrocyte membrane and model phospholipid bilayers
    ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES
    
    M. Suwalsky et al., "The anticancer drug chlorambucil interacts with the human erythrocyte membrane and model phospholipid bilayers", Z NATURFO C, 54(12), 1999, pp. 1089-1095
82. Moroni, G; Farricciotti, A; Cappelletti, M; Ponticelli, C
    Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    G. Moroni et al., "Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents", NEPH DIAL T, 14(5), 1999, pp. 1303-1305
83. Ponticelli, C; Villa, M
    Does cyclosporin have a role in the treatment of membranous nephropathy?
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    C. Ponticelli e M. Villa, "Does cyclosporin have a role in the treatment of membranous nephropathy?", NEPH DIAL T, 14(1), 1999, pp. 23-25
84. Aviles, DH; Irwin, KC; Dublin, LS; Vehaskari, VM
    Aggressive treatment of severe idiopathic focal segmental glomerulosclerosis
    PEDIATRIC NEPHROLOGY
    
    D.H. Aviles et al., "Aggressive treatment of severe idiopathic focal segmental glomerulosclerosis", PED NEPHROL, 13(4), 1999, pp. 298-300
85. Rummel, MJ; Kafer, G; Pfreundschuh, M; Jager, E; Reinhardt, U; Mitrou, PS; Hoelzer, D; Bergmann, L
    Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: A German multicenter phase II study
    ANNALS OF ONCOLOGY
    
    M.J. Rummel et al., "Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: A German multicenter phase II study", ANN ONCOL, 10(2), 1999, pp. 183-188
86. Van Den Neste, E; Bontemps, F; Delacauw, A; Cardoen, S; Louviaux, I; Scheiff, JM; Gillis, E; Leveugle, P; Deneys, V; Ferrant, A; Van den Berghe, G
    Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2 '-deoxyadenosine
    LEUKEMIA
    
    E. Van Den Neste et al., "Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2 '-deoxyadenosine", LEUKEMIA, 13(6), 1999, pp. 918-925
87. Brecher, AS; Rasmusson, E; Riley, C; VanDenBerghe, S
    The effect of chlorambucil upon lysozyme activity
    FUNDAMENTAL & CLINICAL PHARMACOLOGY
    
    A.S. Brecher et al., "The effect of chlorambucil upon lysozyme activity", FUN CL PHAR, 13(1), 1999, pp. 107-112
88. Callea, V; Stelitano, C; Callea, I; Console, G; Brugiatelli, M; Morabito, F
    In vitro drug-induced cytotoxicity predicts clinical response to high-dosechlorambucil in B-cell chronic lymphocytic leukemia
    HAEMATOLOGICA
    
    V. Callea et al., "In vitro drug-induced cytotoxicity predicts clinical response to high-dosechlorambucil in B-cell chronic lymphocytic leukemia", HAEMATOLOG, 84(9), 1999, pp. 863-864
89. Van Gelder, RN; Kaplan, HJ
    Immunosuppression in uveitis therapy
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY
    
    R.N. Van Gelder e H.J. Kaplan, "Immunosuppression in uveitis therapy", SPR SEM IMM, 21(2), 1999, pp. 179-190
90. Savolainen, HA
    Chlorambucil in severe juvenile chronic arthritis: Longterm followup with special reference to amyloidosis
    JOURNAL OF RHEUMATOLOGY
    
    H.A. Savolainen, "Chlorambucil in severe juvenile chronic arthritis: Longterm followup with special reference to amyloidosis", J RHEUMATOL, 26(4), 1999, pp. 898-903
91. Medsger, TA; Silman, AJ; Steen, VD; Black, CM; Akesson, A; Bacon, PA; Harris, CA; Jablonska, S; Jayson, MIV; Jimenez, SA; Krieg, T; Leroy, EC; Maddison, PJ; Russell, ML; Schachter, RK; Wollheim, FA; Zacharaie, H
    A disease severity scale for systemic sclerosis: Development and testing
    JOURNAL OF RHEUMATOLOGY
    
    T.A. Medsger et al., "A disease severity scale for systemic sclerosis: Development and testing", J RHEUMATOL, 26(10), 1999, pp. 2159-2167
92. Setterfield, J; Huilgol, SC; Black, MM
    Generalised granuloma annulare successfully treated with PUVA
    CLINICAL AND EXPERIMENTAL DERMATOLOGY
    
    J. Setterfield et al., "Generalised granuloma annulare successfully treated with PUVA", CLIN EXP D, 24(6), 1999, pp. 458-460
93. Pettersson-Fernholm, T; Vilpo, J; Kosonen, M; Hakala, K; Hovinen, J
    Reactions of 4-bis(2-chloroethyl)aminophenylacetic acid (phenylacetic acidmustard) in physiological solutions
    JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2
    
    T. Pettersson-Fernholm et al., "Reactions of 4-bis(2-chloroethyl)aminophenylacetic acid (phenylacetic acidmustard) in physiological solutions", J CHEM S P2, (10), 1999, pp. 2183-2187
94. Golding, BT; Mitchinson, A; Clegg, W; Elsegood, MRJ; Griffin, RJ
    Protecting-group strategies for the synthesis of N-4-substituted and N-1,N-8-disubstituted spermidines, exemplified by hirudonine
    JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
    
    B.T. Golding et al., "Protecting-group strategies for the synthesis of N-4-substituted and N-1,N-8-disubstituted spermidines, exemplified by hirudonine", J CHEM S P1, (3), 1999, pp. 349-356
95. Tefferi, A; Levitt, R; Li, CY; Schroeder, G; Tschetter, LK; Michalak, JC; Krook, JE; Witzig, TE
    Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    
    A. Tefferi et al., "Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia", AM J CL ONC, 22(5), 1999, pp. 509-516
96. Polenakovik, MH; Grcevska, L
    Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    M.H. Polenakovik e L. Grcevska, "Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy", AM J KIDNEY, 34(5), 1999, pp. 911-917
97. Ahuja, M; Goumenos, D; Shortland, JR; Gerakis, A; Brown, CB
    Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    M. Ahuja et al., "Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?", AM J KIDNEY, 34(3), 1999, pp. 521-529
98. Wells, XE; Bender, VJ; Francis, CL; He-Williams, HM; Manthey, MK; Moghaddam, MJ; Reilly, WG; Whittaker, RG
    Tris and the ready production of drug-fatty acyl conjugates
    DRUG DEVELOPMENT RESEARCH
    
    X.E. Wells et al., "Tris and the ready production of drug-fatty acyl conjugates", DRUG DEV R, 46(3-4), 1999, pp. 302-308
99. Suki, WN; Trimarchi, H; Frommer, JP
    Relapsing membranous nephropathy - Response to therapy of relapses compared to that of the original disease
    AMERICAN JOURNAL OF NEPHROLOGY
    
    W.N. Suki et al., "Relapsing membranous nephropathy - Response to therapy of relapses compared to that of the original disease", AM J NEPHR, 19(4), 1999, pp. 474-479
100. Shetty, AK; Zganjar, BE; Ellis, GS; Ludwig, IH; Gedalia, A
     Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis
     JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS
     
     A.K. Shetty et al., "Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis", J PEDIAT OP, 36(3), 1999, pp. 125-128